-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $185

Benzinga·04/23/2025 13:04:40
Listen to the news
Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $175 to $185.